{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T08:07:18Z","timestamp":1772784438042,"version":"3.50.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2019,6,10]],"date-time":"2019-06-10T00:00:00Z","timestamp":1560124800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,6,10]],"date-time":"2019-06-10T00:00:00Z","timestamp":1560124800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["DA043204"],"award-info":[{"award-number":["DA043204"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["DA045011"],"award-info":[{"award-number":["DA045011"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["DA039167"],"award-info":[{"award-number":["DA039167"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"crossref","award":["DA011792"],"award-info":[{"award-number":["DA011792"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1007\/s00213-019-05286-0","type":"journal-article","created":{"date-parts":[[2019,6,10]],"date-time":"2019-06-10T17:02:26Z","timestamp":1560186146000},"page":"3271-3279","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Self-administration of benzodiazepine and cocaine combinations by male and female rhesus monkeys in a choice procedure: role of \u03b11 subunit\u2013containing GABAA receptors"],"prefix":"10.1007","volume":"236","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8528-0926","authenticated-orcid":false,"given":"Sally L.","family":"Huskinson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K. B.","family":"Freeman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. K.","family":"Rowlett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,6,10]]},"reference":[{"key":"5286_CR1","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1124\/jpet.109.158303","volume":"332","author":"NA Ator","year":"2010","unstructured":"Ator NA, Atack JR, Hargreaves RJ, Burns HD, Dawson GR (2010) Reducing abuse liability of GABAA\/benzodiazepine ligands via selective partial agonist efficacy at \u03b11 and \u03b12\/3 subtypes. J Pharmacol Exp Ther 332:4\u201316. \n                    https:\/\/doi.org\/10.1124\/jpet.109.158303","journal-title":"J Pharmacol Exp Ther"},{"key":"5286_CR2","doi-asserted-by":"publisher","first-page":"281768","DOI":"10.1155\/2012\/281768","volume":"2012","author":"ML Banks","year":"2012","unstructured":"Banks ML, Negus SS (2012) Preclinical determinants of drug choice under concurrent schedules of drug self-administration. Adv Pharmacol Sci 2012:281768\u2013281717. \n                    https:\/\/doi.org\/10.1155\/2012\/281768","journal-title":"Adv Pharmacol Sci"},{"key":"5286_CR3","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1007\/BF00431693","volume":"86","author":"J Bergman","year":"1985","unstructured":"Bergman J, Johanson CE (1985) The reinforcing properties of diazepam under several conditions in the rhesus monkey. Psychopharmacol 86:108\u2013113","journal-title":"Psychopharmacol"},{"key":"5286_CR4","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/BF02247378","volume":"126","author":"SD Comer","year":"1996","unstructured":"Comer SD, Carroll ME (1996) Oral caffeine pretreatment produced modest increases in smoked cocaine self-administration in rhesus monkeys. Psychopharmacol 126:281\u2013285","journal-title":"Psychopharmacol"},{"key":"5286_CR5","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1038\/npp.2014.41","volume":"39","author":"E Engin","year":"2014","unstructured":"Engin E, Bakhurin KI, Smith KS, Hines RM, Reynolds LM, Tang W, Sprengel R, Moss SJ, Rudolph U (2014) Neural basis of benzodiazepine reward: requirement for \u03b12 containing GABAA receptors in the nucleus accumbens. Neuropsychopharmacol 39:1805\u20131815. \n                    https:\/\/doi.org\/10.1038\/npp.2014.41","journal-title":"Neuropsychopharmacol"},{"key":"5286_CR6","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1016\/j.tips.2018.04.003","volume":"39","author":"E Engin","year":"2018","unstructured":"Engin E, Benham RS, Rudolph U (2018) An emerging circuit of pharmacology of GABAA receptors. Trends Pharmacol Sci 39:710\u2013732. \n                    https:\/\/doi.org\/10.1016\/j.tips.2018.04.003","journal-title":"Trends Pharmacol Sci"},{"key":"5286_CR7","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1016\/j.neuropharm.2010.08.011","volume":"59","author":"BD Fischer","year":"2010","unstructured":"Fischer BD, Licata SC, Edwankar RV, Wang ZJ, Huang S, He X, Yu J, Zhou H, Johnson EM Jr, Cook JM, Furtmuller R, Ramerstorfer J, Sieghart W, Roth BL, Majumder S, Rowlett JK (2010) Anxiolytic-like effects of 8-acetylene imidazobenzodiazepines in a rhesus monkey conflict procedure. Neuropharmacol 59:612\u2013618. \n                    https:\/\/doi.org\/10.1016\/j.neuropharm.2010.08.011","journal-title":"Neuropharmacol"},{"key":"5286_CR8","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1007\/s00213-010-2142-y","volume":"215","author":"BD Fischer","year":"2011","unstructured":"Fischer BD, Atack JR, Platt DM, Reynolds DS, Dawson GR, Rowlett JK (2011) Contribution of GABA(a) receptors containing \u03b13 subunits to the therapeutic-related and side effects of benzodiazepine-type drugs in monkeys. Psychopharmacol 215:311\u2013319. \n                    https:\/\/doi.org\/10.1007\/s00213-010-2142-y","journal-title":"Psychopharmacol"},{"key":"5286_CR9","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1007\/s00213-013-2975-2","volume":"227","author":"BD Fischer","year":"2013","unstructured":"Fischer BD, Teixeira LP, van Linn ML, Namjoshi OA, Cook JM, Rowlett JK (2013) Role of gamma-aminobutyric acid type A (GABAA) receptor subtypes in acute benzodiazepine physical dependence-like effects: evidence from squirrel monkeys responding under a schedule of food presentation. Psychopharmacol 227:347\u2013354. \n                    https:\/\/doi.org\/10.1007\/s00213-013-2975-2","journal-title":"Psychopharmacol"},{"key":"5286_CR10","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.drugalcdep.2015.10.026","volume":"158","author":"BD Fischer","year":"2016","unstructured":"Fischer BD, Platt DM, Rallapalli SK, Namjoshi OA, Cook JM, Rowlett JK (2016) Antagonism of triazolam self-administration in rhesus monkeys responding under a progressive-ratio schedule: in vivo apparent pA2 analysis. Drug Alcohol Depend 158:22\u201329. \n                    https:\/\/doi.org\/10.1016\/j.drugalcdep.2015.10.026","journal-title":"Drug Alcohol Depend"},{"key":"5286_CR11","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s00213-009-1637-x","volume":"207","author":"KB Freeman","year":"2009","unstructured":"Freeman KB, Woolverton WL (2009) Self-administration of cocaine and nicotine mixtures by rhesus monkeys. Psychopharmacol 207:99\u2013106. \n                    https:\/\/doi.org\/10.1007\/s00213-009-1637-x","journal-title":"Psychopharmacol"},{"key":"5286_CR12","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/s00213-010-2131-1","volume":"215","author":"KB Freeman","year":"2011","unstructured":"Freeman KB, Woolverton WL (2011) Self-administration of cocaine and remifentanil by monkeys: choice between single drugs and mixtures. Psychopharmacol 215:281\u2013290. \n                    https:\/\/doi.org\/10.1007\/s00213-010-2131-1","journal-title":"Psychopharmacol"},{"key":"5286_CR13","doi-asserted-by":"publisher","first-page":"2751","DOI":"10.1007\/s00213-014-3436-2","volume":"231","author":"KB Freeman","year":"2014","unstructured":"Freeman KB, Naylor JE, Prisinzano TE, Woolverton WL (2014) Assessment of the kappa opioid agonist, salvinorin A, as a punisher of drug self-administration in monkeys. Psychopharmacol 231:2751\u20132758. \n                    https:\/\/doi.org\/10.1007\/s00213-014-3436-2","journal-title":"Psychopharmacol"},{"key":"5286_CR14","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1007\/s00213-014-3661-8","volume":"232","author":"SL Huskinson","year":"2015","unstructured":"Huskinson SL, Freeman KB, Woolverton WL (2015) Self-administration of cocaine and remifentanil by monkeys under concurrent-access conditions. Psychopharmacol 232:321\u2013330. \n                    https:\/\/doi.org\/10.1007\/s00213-014-3661-8","journal-title":"Psychopharmacol"},{"key":"5286_CR15","doi-asserted-by":"publisher","first-page":"2353","DOI":"10.1007\/s00213-017-4659-9","volume":"234","author":"SL Huskinson","year":"2017","unstructured":"Huskinson SL, Freeman KB, Petry NM, Rowlett JK (2017) Choice between variable and fixed cocaine injections in male rhesus monkeys. Psychopharmacol 234:2353\u20132364. \n                    https:\/\/doi.org\/10.1007\/s00213-017-4659-9","journal-title":"Psychopharmacol"},{"key":"5286_CR16","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1124\/jpet.104.081612","volume":"313","author":"SC Licata","year":"2005","unstructured":"Licata SC, Platt DM, Cook JM, Sarma PB, Griebel G, Rowlett JK (2005) Contribution of GABAA receptor subtypes to the anxiolytic-like, motor, and discriminative stimulus effects of benzodiazepines: studies with the functionally selective ligand SL651498 [6-fluoro-9-methyl-2-phenyl-4-(pyrrolidin-1-yl-carbonyl)-2,9-dihydro-1H-pyridol[3,4-b]indol-1-one]. J Pharmacol Exp Ther 313:1118\u20131125. \n                    https:\/\/doi.org\/10.1124\/jpet.104.081612","journal-title":"J Pharmacol Exp Ther"},{"key":"5286_CR17","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1126\/science.290.5489.131","volume":"290","author":"K L\u00f6w","year":"2000","unstructured":"L\u00f6w K, Crestani F, Keist R, Benke D, Br\u00fcnig I, Benson JA, Fritschy JM, R\u00fclicke T, Bluethmann H, M\u00f6hler H, Rudolph U (2000) Molecular and neuronal substrate for the selective attenuation of anxiety. Science 290:131\u2013134 Erratum in: science 290:936c (2000)","journal-title":"Science"},{"key":"5286_CR18","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1038\/75761","volume":"3","author":"RM McKernan","year":"2000","unstructured":"McKernan RM, Rosahl TW, Reynolds DS, Sur C, Wafford KA, Atack JR, Farrar S, Myers J, Cook G, Ferris P, Garrett L, Bristow L, Marshall G, Macaulay A, Brown N, Howell O, Moore KW, Carling RW, Street LJ, Castro JL, Ragan CI, Dawson GR, Whiting PJ (2000) Sedative but not anxiolytic properties of benzodiazepines are mediated by the GABA(A) receptor alpha1 subtype. Nat Neurosci 3:587\u2013592. \n                    https:\/\/doi.org\/10.1038\/75761","journal-title":"Nat Neurosci"},{"key":"5286_CR19","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1124\/jpet.105.094474","volume":"316","author":"NO Mirza","year":"2006","unstructured":"Mirza NO, Nielsen E\u00d8 (2006) Do subtype-selective \ud6fe-aminobutyric acidA receptor modulators have a reduced propensity to induce physical dependence in mice? J Pharmacol Exp Ther 316:1378\u20131385. \n                    https:\/\/doi.org\/10.1124\/jpet.105.094474","journal-title":"J Pharmacol Exp Ther"},{"key":"5286_CR20","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.neuropharm.2018.01.036","volume":"136","author":"RW Olsen","year":"2018","unstructured":"Olsen RW (2018) GABAA receptor: positive and negative allosteric modulators. Neuropharmacol 136:10\u201322. \n                    https:\/\/doi.org\/10.1016\/j.neuropharm.2018.01.036","journal-title":"Neuropharmacol"},{"key":"5286_CR21","doi-asserted-by":"publisher","first-page":"2531","DOI":"10.1038\/npp.2012.115","volume":"37","author":"LM Reynolds","year":"2012","unstructured":"Reynolds LM, Engin E, Tantillo G, Lau HM, Muschamp JW, Carlezon WA Jr, Rudolph U (2012) Differential roles of GABAA receptor subtypes in benzodiazepine-induced enhancement of brain-stimulation reward. Neuropsychopharm 37:2531\u20132540. \n                    https:\/\/doi.org\/10.1038\/npp.2012.115","journal-title":"Neuropsychopharm"},{"key":"5286_CR22","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1073\/pnas.040562110","volume":"102","author":"JK Rowlett","year":"2005","unstructured":"Rowlett JK, Platt DM, Lelas S, Atack JR, Dawson GR (2005) Different GABAA receptor subtypes mediate the anxiolytic, abuse-related, and motor effects of benzodiazepine-like drugs in primates. PNAS 102:915\u2013920. \n                    https:\/\/doi.org\/10.1073\/pnas.040562110","journal-title":"PNAS"},{"key":"5286_CR23","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/nrd3502","volume":"10","author":"U Rudolph","year":"2011","unstructured":"Rudolph U, Knoflach F (2011) Beyond classical benzodiazepines: novel therapeutic potential of GABAA receptor subtypes. Nat Rev Drug Discov 10:685\u2013697. \n                    https:\/\/doi.org\/10.1038\/nrd3502","journal-title":"Nat Rev Drug Discov"},{"key":"5286_CR24","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1097\/00008877-199404000-00006","volume":"5","author":"S Schenk","year":"1994","unstructured":"Schenk S, Valadez A, Horger BA, Snow S, Wellman PJ (1994) Interactions between caffeine and cocaine in tests of self-administration. Behav Pharmacol 5:153\u2013158","journal-title":"Behav Pharmacol"},{"key":"5286_CR25","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.1007\/s00213-017-4615-8","volume":"234","author":"KL Schwienteck","year":"2017","unstructured":"Schwienteck KL, Guanguan L, Poe MM, Cook JM, Banks ML, Negus SS (2017) Abuse-related effects of subtype-selective GABAA receptor positive allosteric modulators in an assay of intracranial self-stimulation in rats. Psychopharmacol 234:2091\u20132102. \n                    https:\/\/doi.org\/10.1007\/s00213-017-4615-8","journal-title":"Psychopharmacol"},{"key":"5286_CR26","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1038\/npp.2012.265","volume":"38","author":"NM Shinday","year":"2013","unstructured":"Shinday NM, Sawyer EK, Fischer BD, Platt DM, Licata SC, Atack JR, Dawson GR, Reynolds DS, Rowlett JK (2013) Reinforcing effects of compounds lacking intrinsic efficacy at \u03b11 subunit-containing GABAA receptor subtypes in midazolam- but not cocaine-experienced rhesus monkeys. Neuropsychopharm 38:1006\u20131014. \n                    https:\/\/doi.org\/10.1038\/npp.2012.265","journal-title":"Neuropsychopharm"},{"key":"5286_CR27","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1124\/pr.117.014449","volume":"70","author":"W Sieghart","year":"2018","unstructured":"Sieghart W, Savic M (2018) International union of basic and clinical pharmacology. CVI: GABAA receptor subtype- and function-selective ligands: key issues in translation to humans. Pharmacol Rev 70:836\u2013878. \n                    https:\/\/doi.org\/10.1124\/pr.117.014449","journal-title":"Pharmacol Rev"},{"key":"5286_CR28","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1038\/nature08758","volume":"463","author":"KR Tan","year":"2010","unstructured":"Tan KR, Brown M, Labouebe G, Yvon C, Creton C, Fritschy M, Rudolph U, Luscher C (2010) Neural bases for addictive properties of benzodiazepins. Nature 463:769\u2013774. \n                    https:\/\/doi.org\/10.1038\/nature08758","journal-title":"Nature"},{"key":"5286_CR29","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.tins.2011.01.004","volume":"34","author":"KR Tan","year":"2011","unstructured":"Tan KR, Rudolph U, Luscher C (2011) Hooked on benzodiazepines: GABAA receptor subtypes and addiction. Trends Neurosci 34:188\u2013197. \n                    https:\/\/doi.org\/10.1016\/j.tins.2011.01.004","journal-title":"Trends Neurosci"},{"key":"5286_CR30","doi-asserted-by":"publisher","first-page":"e43054","DOI":"10.1371\/journal.pone.0043054","volume":"7","author":"CH Vinkers","year":"2012","unstructured":"Vinkers CH, van Oorschot R, Nielsen EO, Cook JM, Hansen HH, Groenink L, Olivier B, Mirza NR (2012) GABAA receptor \u237a subunits differentially contribute to diazepam tolerance after chronic treatment. PLoS One 7:e43054. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0043054","journal-title":"PLoS One"},{"key":"5286_CR31","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1124\/jpet.117.240200","volume":"362","author":"PF Weed","year":"2017","unstructured":"Weed PF, France CP, Gerak LR (2017) Preference for an opioid\/benzodiazepine mixture over an opioid along using a concurrent choice procedure in rhesus monkeys. J Pharmacol Exp Ther 362:59\u201366. \n                    https:\/\/doi.org\/10.1124\/jpet.117.240200","journal-title":"J Pharmacol Exp Ther"},{"key":"5286_CR32","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/S0091-3057(03)00219-3","volume":"76","author":"WL Woolverton","year":"2003","unstructured":"Woolverton WL (2003) A novel choice method for studying drugs as punishers. Pharmacol Biochem Behav 76:125\u2013131","journal-title":"Pharmacol Biochem Behav"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-019-05286-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00213-019-05286-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-019-05286-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,8]],"date-time":"2020-06-08T23:05:12Z","timestamp":1591657512000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00213-019-05286-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,10]]},"references-count":32,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["5286"],"URL":"https:\/\/doi.org\/10.1007\/s00213-019-05286-0","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,10]]},"assertion":[{"value":"4 April 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 May 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"On behalf of all authors, the corresponding author states that there is no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}